Oxeia Biopharmaceuticals, Inc. — Form D
Oxeia Biopharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-06-16. The offering totals $310K, of which $310K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-06-16
- Form: D
- Accession: 0000897069-14-000300
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $310K
- Amount sold: $310K
- Investors: 5
- Date of first sale: 2014-06-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-219239
Issuer
- Name: Oxeia Biopharmaceuticals, Inc.
- CIK: 0001610315
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 12463 CARMEL PARK DRIVE, SAN DIEGO, CA, 92130
- Phone: (619) 213-7697
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Amit Munshi | Director | Westlake Village, CA |
| Kartik Shah | Director | New York, NY |
| Amit Munshi | Executive Officer | Westlake Village, CA |
| Kartik Shah | Executive Officer | New York, NY |
| Amit Munshi | Promoter | Westlake Village, CA |
| Kartik Shah | Promoter | New York, NY |
More